Table 2.
Post-COVID-19 neuropsychological assessment.
| Psychological, fatigue, and autonomy | |
|---|---|
| GAD-7 (anxiety) | |
| Absent, n (%) | 89 (66.4) |
| Mild, n (%) | 28 (20.9) |
| Moderate, n (%) | 10 (7.5) |
| Severe, n (%) | 7 (5.2) |
| PHQ-9 (depression) | |
| Absent, n (%) | 81 (60.4) |
| Mild, n (%) | 28 (20.9) |
| Moderate, n (%) | 16 (11.9) |
| Moderately severe, n (%) | 5 (3.7) |
| Severe, n (%) | 4 (3.0) |
| Brief fatigue index | |
| Absence, n (%) | 37 (27.6) |
| Mild, n (%) | 48 (35.8) |
| Moderate, n (%) | 44 (32.8) |
| Severe, n (%) | 3 (2.2) |
| IADL partially autonomous, n (%) | 6 (4.5) |
| Mild psychiatric sequelae1, n (%) | 45 (33.6) |
| Moderate or severe psychiatric sequelae2, n (%) | 29 (21.6) |
| Psychiatric symptoms3, n (%) | 74 (55.2) |
| Neurocognitive functions | |
| Abnormal TICS-m, n (%) | 26 (19.4) |
| Abnormal Hayling and Brixton, n (%) | 52 (38.8) |
| Abnormal O-TMT-A, n (%) | 12 (9.0) |
| Abnormal O-TMT-B, n (%) | 12 (9.0) |
| Abnormal O-TMT A or B, n (%) | 18 (13.4) |
| Cognitive impairment,4 n (%) | 78 (58.2) |
| Executive dysfunction,5 n (%) | 75 (56.0) |
| Time between COVID and interview, months, mean (min-max) | 7.7 (1.3–16.5) |
1Represents mild anxiety or mild depression.2Represents moderate-to-severe anxiety or moderate-to-severe depression.3Represents mild, moderate and severe psychiatric sequelae.4Represents an abnormal result on at least one of the following tests: Hayling and Brixton, TMT-A, or TMT-B, or an ambiguous or impaired score on the TICS-m.5Represents an abnormal result on at least one of the following tests: Hayling and Brixton, TMT-A, or TMT-B.